Anand N, Chowdhry PN (2013). Anti-tumour potential of active compounds (polysaccharides) of wild mushrooms from Rajouri Dist. of Jammu & Kashmir, India. Int. J. Pharm. Sci. Res. 4(5):1743-1746.

Bell SM, Pham JN, Fisher GT (2009). Antibiotic susceptibility testing by the CDS method. A Manual for Medical and Veterinary Laboratories. The Antibiotic Reference Laboratory. Fifth Edition, South Eastern Area Laboratory Services Randwick NSW 2031 Australia ISBN 978-0-646-51681-3.

Chang ST (1995). Ganoderma - The leader in production and technology of mushroom nutriceuticals. In Proc 6th Int Symp Recent Adv Ganoderma lucidum Res (ed. B. K. Kim, I. H. Kim and Y. S. Kim). The Pharmaceutical Society of Korea, Seoul, Korea. pp. 43-52.

Chen AW, Miles PG (1996a). Biomedical research and the application of mushroom nutriceuticals from Ganoderma lucidum. In Proc 2nd Int Conf. Mush. Biol. Mush. Prod. (ed. D. J. Royse). University Park, Pennsylvania. pp. 161-175.

Crittenden PD, Davis JC, Hawksworth DL, Campbell FS (1995). Attempted isolation and success in culturing of a broad spectrum of lichen forming and lichenocolous fungi. New Phytol. 130:267-297.
Crossref

Dandan L, Zheng H, Zhigang L, Wenjuan T, Liang L (2009). Chemical composition and antimicrobial activity of essential oil isolated from the cultured mycelia of Ganoderma japonicum. J. Nanjing Med. Univ. 23(3):168-172.
Crossref

Dixit A, Dikshit SN (1982). Cedrus oil-A promising antifungal agent. Indian Perfum. 26: 216-227.

Dobson CM (2004). Chemical space in biology. Nature 432:824-828.
Crossref

Doughari JH (2006) Antimicrobial activity of Tamarindus indica Linn. Trop. J. Pharma Res. 5:597-603.

Edelstein L, Segel LA (1983). Growth and metabolism in mycelial fungi. J. Theor. Biol. 104:187-210.
Crossref

Fatima E, Smania A, Delle F, Rosendo AY, Paulert R, Smania A (2007). Antimicrobial activity of methyl australate from Ganoderma australe. Rev. Bras. Farmacogn. 17(1):14-16.
Crossref

Fleming A (1929). On the antibacterial action of a Penicillium with special reference to their use in the isolation of B. influenzae. Br. J. Exp. Pathol. 10:226-236.
Pubmed

Florianowicz T (1998). Penicillium expansum growth and production of patulin in the presence of benzoic acid and its derivatives. Acta Microbiol. Pol. 47:45-53.
PMid:9735057

Gao XX, Fei XF, Wang BX, Zhang J, Gong YJ, Minami M, Nagata T, Ikejima T (2000). Effects of polysaccharides (FI0-b) from mycelium of Ganoderma tsugae on proinflammatory cytokine production by THP-1 cells and human PBMC (I). Acta Pharmacol. Sin. 21:1179-1185.
Pubmed

Gao Y, Zhou S, Huang M, Xu A (2003). Antibacterial and antiviral value of the genus Ganoderma P. Karst. species (Aphyllophoromycetideae): A review. Int. J. Med. Mushrooms 5:235-246.
Crossref

Grigansky AP, Solomko EF, Kirchoff B (1999). Mycelial growth of medicinal mushroom Hericium erinaceus (Bull.:Fr.) Pers. in pure culture. Int. J. Med. Mushrooms 1:81-87.
Crossref

Grover RK, Morre JD (1962). Toxicometric studies of fungicides against brown rot organisms Sclerotinia fructicola and S. lexa. Phytopathology 52:876-880.

Henry FC, Frank RD (2009). Waves of resistance: Staphylococcus aureus in the antibiotic era. Nat. Rev. Microbiol. 7:629-641.
Crossref

Jiao M (2003). The analysis of drug resistance and bacteria of acute respiratory tract infection in children. Acta Universitatis Medicinalis Nanjing. 23: 82-84.

Kim SW, Hwang HJ, Xu CP, Sung JM, Choi JW, Yun JW (2003). Optimization of submerged culture process for the production of mycelial biomass and exo-polysaccharides by Cordyceps militaris C738. J. Appl. Microbiol. 94:120-126.
Crossref

Klaus A, Niksic M (2007). Influence of the extracts isolated from Ganoderma lucidum mushroom on some microorganisms. Proc. Nat. Sci. 113:219-226.

Larena II, Melgarejo P (1996). Biological Control of Monilinia laxa and Fusarium oxysporum f. sp. lycopersici by a Lytic Enzyme-Producing Penicillium purpurogenum. Biol. Control 6:361-367.
Crossref

Lehrer RI, Rosenman M, Harwig SSSL, Jackson R, Eisenhauer P (1991). Ultrasensitive assay for endogenous antimicrobial polypeptides. J. Immunol. Methods 137:167-173.
Crossref

Li S, Xiao GY, Zhou GP, Cai JY, Huang YP, Li Q (2008). The analysis of the drugs used by the patiants with MRSA infection. Modem Hosp. 8:19-21.

Lin SB, Li CH, Lee SS, Kan LS (2003). Triterpene-enriched extracts from Ganoderma lucidum inhibit growth of hepatoma cells via suppressing protein kinase C, activating mitogen-activated protein kinases and G2-phase cell cycle arrest. Life Sci. 72:2381-2390.
Crossref

Liu D, Hua Z, Liua Z, Yanga, Tub W, Lia L (2009). Chemical composition and antimicrobial activity of essential oil isolated from the cultured mycelia of Ganoderma japonicum. J. Nanjing Med. Univ. 23(3):168-172.
Crossref

Lorenzen K, Anke T (1998). Basidiomycetes as a source for new bioactive natural products. Curr. Org. Chem. 2:329-364.

Mayordomo I, Randez-Gil F, Prieto JA (2000). Isolation, purification, and characterization of a cold-active lipase from Aspergillus nidulans. J. Agric. Food. Chem. 48:105-109.
Crossref

McGowan JEJ (2001). Economic impact of antimicrobial resistance. Emerg. Infect. Dis. 7:286-292.
Crossref

Monroe S, Polk R (2000). Antimicrobial use and bacterial resistance. Curr. Microbiol. 3:496-501.
Crossref

Mothana RAA, Awadh Ali NA, Jansen R, Wegner U, Mentel R, Lindequist U (2003). Antiviral lanostanoid triterpenes from the fungus Ganoderma pfeifferi. Fitoterapia 74:177-180.
Crossref

National Committtee for Clinical Laboratory Standards-NCCLS (2001). Performance Standards for Antimicrobial Susceptibility Testing; 11th Information Supplement. Approved Standard M2-A7 and M7-A5. Wayne, PA, U.S.A.

Newman DJ, Cragg GM, Snader KM (2003). Natural products as sources of new drugs over the period 1981-2002. J. Nat. Prod. 66:1022-1037.
Crossref

Pointing SB, Hyde KD (2001). Bio-exploitation of filamentous fungi, First edition. Fungal Diversity Press, Hon g Kong, China. p. 219.

Prasad Y, Wesely WEG (2008). Antibacterial Activity of the bio-multidrug (Ganoderma lucidum) on multidrug resistant Staphylococcus aureus (MRSA). Adv. Biotech 9-16.

Rodrigues KF, Hesse M, Werner C (2000). Antimicrobial activities of secondary metabolites produced by endophytic fungi from Spondias mombin. J. Basic Microbiol. 40:261-267.
Crossref

Sarker SD, Nahar L, Kumarasamy (2007). Microtiter plate-based antibacterial assay incorporating resazurin as an indicator of cell growth and its application in the in vitro antibacterial screening of phytochemicals. Methods 42(4):321-324.
Crossref

Shah P, Modi HA, Shukla MD, Lahiri SK (2014). Preliminary phytochemical analysis and antibacterial activity of Ganoderma lucidum collected from dang district of Gujarat, India. Int. J. Curr. Microbiol. Appl. Sci. 3(3):246-255.

Smania EFA, Della MF, Smania AJ, Yunes RA, Cuneo RS (2003). Antifungal activity of sterol and triterpenes isolated from Ganoderma annulare. Fitoterapia 74:375-377.
Crossref

Wang L, Wang YH, Zhang KC (2004). A Study on the effect of 5 kinds of Chinese traditional medicines on submerged fermentation of Ganoderma lucidum and its fermented broth on chronic bronchitis. Edible Fungi China 5:39-40.